All IndicationsOncology
ποΈ
HER2-positive colorectal cancer in adult patients who have failed treatment with oxaliplatin, fluorouracil, and irinotecan
1
Companies
1
Drug Programs
0
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| HZNP Hengrui Pharmaceuticals | recombinant humanized anti-HER2 monoclonal antibody-drug conjugate (ηεΊ·ζ²ε¦₯η εζ) | Approved | β | β | β |
Development Stage Distribution
Approved
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data β past performance doesn't guarantee future results. Do your own research.